Scholars Central

Conference abstractPublished 21 Jun 2022

Personalised cannabinoids based treatments transforming healthcare delivery for EU ageing population

Authors: Pavel Kubu

International Cannabis and Cannabinoids Institute, Prague

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Europe will be the largest medical cannabis market in the world with a market of over 739 million people, and total healthcare spend of âÂ?¬1.49t. Both business and government realize that this thriving industry has a future but the development of new treatment methods based on cannabinoids medications must be based on conclusive research. A record level of investment in research has been seen in new medical cannabis cultivation facilities opening across Europe. One of the results has been an ever increasing list of predominantly chronic conditions of ageing population that cannabinoid based therapies can treat. As the list grows, so does the potential patient base. Clinical experience and initial evidence significantly indicate needs for personalisation of cannabis treatment with eHealth tools to provide efficient cure while keeping the quality of life on ambient level for EU ageing population. Keywords-Cannabis, Cannabinoid Medication, Ageing Population, Personalisation

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Pavel Kubu”